AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Alzheimer s Disease

DUVAX: A Phase 1 Alzheimer's Vaccine Study Targeting Amyloid-Beta and Tau NCT07142278Phase 11 site๐Ÿ“ Miami Lakes Nuravax, Inc. ยท Tests: DUVAX 200 ยตg, DUVAX 400 ยตg, Placebo (Adjuvant only) Improving Executive Control in Cognitively Healthy Older Adults: the MUltitasking STrategy (MUST) Study NCT06995638NA1 site๐Ÿ“ Newark Rutgers, The State University of New Jersey ยท Tests: Web-based Cognitive Training (with strategy), Web-based Cognitive Training (without strategy) Working Memory Training in Patients with Mild Cognitive Impairment NCT06734286NA1 site๐Ÿ“ Phoenix St. Joseph's Hospital and Medical Center, Phoenix ยท Tests: CogMed Crownlands Observing Progression With Neurons Study NCT07611396n/a1 site๐Ÿ“ Germantown Crownlands A Clinical Study Evaluating the Diagnostic Performance and Safety of PET for the Deposition of Aฮฒ Plaques in the Brain of Participants With Normal Cognitive Function, MCI and AD Using [18F]Fluorbetazine Injection NCT07764679Phase 31 site๐Ÿ“ Beijing HTA Co., Ltd. ยท Tests: [18F]Fluorbetazine injection Establishment of the Chinese Preclinical Alzheimer's Disease Study With Multiple Neuroimaging NCT06827678n/a1 site๐Ÿ“ Shanghai Huashan Hospital ยท Tests: No Intervention: Observational Cohort An Evaluation of Treatments for Sustained Clinical Response (18 Months) in Symptomatic Alzheimer's Disease NCT07724132Phase 32 sites๐Ÿ“ Cambridge๐Ÿ“ Chertsey University College, London ยท Tests: Placebo, Atomoxetine, Metformin 1000 mg Oral Tablet Remote tDCS and Chair Yoga for Chronic Knee Pain in Alzheimer's Patients NCT07303998NA1 site๐Ÿ“ Tucson University of Arizona ยท Tests: Active tDCS paired with active online chair yoga Precision Medicine and Neurodegenerative Diseases: Advanced Systems for the Diagnosis and Treatment of Parkinson's Disease and Alzheimer's Disease. NCT07467460n/a1 site๐Ÿ“ Pozzilli Neuromed IRCCS Long Term Effect of Brain Stimulation in PPA NCT07158216NA1 site๐Ÿ“ Madrid Hospital San Carlos, Madrid ยท Tests: TMS, tDCS, Sham TMS, Sham tDCS TACS to Engage Theta-Gamma Coupling and Enhance Working Memory in Patients With MCI (tACS-MCI) NCT06783283NA1 site๐Ÿ“ Toronto Centre for Addiction and Mental Health ยท Tests: Transcranial Alternating Current Stimulation, Sham tACS LEvetiracetam to Prevent Seizures in Symptomatic Alzheimer's Disease in Adults With Down Syndrome NCT07234695Phase 35 sites๐Ÿ“ Granada๐Ÿ“ Donostia / San Sebastian๐Ÿ“ Santander Fundaciรณ Institut de Recerca de l'Hospital de la Santa Creuโ€ฆ ยท Tests: Levetiracetam 500mg, Placebo Transcranial Pulse Stimulation. a Potential Treatment for Early Dementia NCT06730438NA2 sites๐Ÿ“ Lโ€™Aquila๐Ÿ“ Lโ€™Aquila Francesca Pistoia ยท Tests: Transcranial Pulse Stimulation NON-INVASIVE BRAIN STIMULATION FOR MEMORY LOSS IN EARLY ALZHEIMER'S DISEASE NCT07667478NA1 site๐Ÿ“ Houston Chi-Ying (Roy) Lin ยท Tests: repetitive transcranial magnetic stimulation (rTMS), sham repetitive transcranial magnetic stimulation rTMS An Open Label Dose Escalation Study of VY1706 in Participants With Early Alzheimer's Disease NCT07764146Phase 12 sites๐Ÿ“ Maitland๐Ÿ“ Orlando Voyager Therapeutics ยท Tests: VY1706 Low dose, VY1706 Mid dose, VY1706 High Dose, Anti-AAV9 Total Antibody (TAb) Assay Development of Measures to Screen for Financial Hardship in Alzheimer's Disease and Dementia NCT06922188n/a1 site๐Ÿ“ Seattle Fred Hutchinson Cancer Center The Clinical Study of Synaptic Plasticity-based Lencanumab for the Treatment of Early Alzheimer's Disease NCT06871839n/a1 site๐Ÿ“ Beijing Cuibai Wei๏ผŒClinical Professor ยท Tests: Lecanemab treatment group, Conventional anti-dementia treatment group Development of a Home Test for Measuring Blood P-tau217 in Alzheimer's Disease Using the Tasso Lancet Device NCT07701161n/a5 sites๐Ÿ“ Chicago๐Ÿ“ Dearborn๐Ÿ“ Flint Neurogen Biomarking LLC PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) NCT07169630Phase 11 site๐Ÿ“ Bethesda National Institute of Mental Health (NIMH) ยท Tests: 18F-PF974, 18F-florbetaben Infrared Light for Memory Loss in Mild Cognitive Impairment (MCI) NCT06618807NA1 site๐Ÿ“ Toronto Unity Health Toronto ยท Tests: Active tPBM device, Sham device Efficacy and Safety of Transcranial Magnetic Stimulation in Treatment of Alzheimer's Disease NCT07324161NA1 site๐Ÿ“ Fuzhou Fujian Medical University Union Hospital ยท Tests: rTMS, sham rTMS, Accelerated rTMS Ultrasonic Debris Clearance to Promote Brain Resilience NCT07573982NA1 site๐Ÿ“ Stanford Stanford University ยท Tests: Ultrasonic Debris Clearance, sham The Monument Test : A New Tool for Assessing the Ability to Name and Identify Unique Entities. (TeDIMO) NCT07367880n/a1 site๐Ÿ“ Grenoble University Hospital, Grenoble ยท Tests: Identification and naming task [18F]NIDF PET Imaging in Tau-related Diseases NCT07306598n/a3 sites๐Ÿ“ Hefei๐Ÿ“ Qingdao๐Ÿ“ Tianjin Tianjin Medical University Designing Care Management for Hospice Transitions for Persons Living With Advanced Dementia NCT07182357NA1 site๐Ÿ“ New York New York University ยท Tests: Dementia Care Management Checklist for Hospice Transitions SAD Study of CGB3002 in Healthy Participants NCT07660341Phase 11 site๐Ÿ“ Melbourne ChainGen Biopharma Ltd ยท Tests: CGB3002 0.08 mg/kg, CGB3002 0.4 mg/kg, CGB3002 1.2 mg/kg, CGB3002 3.6 mg/kg, CGB3002 7.2 mg/kg Speech and Language Interventions for Italian People With PPA NCT06739967n/a2 sites๐Ÿ“ Bari๐Ÿ“ Milan Istituti Clinici Scientifici Maugeri SpA ยท Tests: Behavioral Treatment A Study of Silkworm Pupa Powder Intervention in the Nutritional Status of Patients With Alzheimer's Disease. NCT07059871NA1 site๐Ÿ“ Hangzhou Zhejiang Hospital ยท Tests: Silkworm pupa powder, Placebo TMS for Cognitive Decline in Aging and Preclinical AD NCT06956300NA1 site๐Ÿ“ Boston Massachusetts General Hospital ยท Tests: Active rTMS, Sham rTMS Study to Evaluate the Efficacy and Safety of KDS2010 in Patients With Alzheimer's Disease With Mild Cognitive Impairment and Mild Dementia Due to Alzheimer's Disease NCT07027072Phase 28 sites๐Ÿ“ Gwangju๐Ÿ“ Guri-si๐Ÿ“ Suwon NeuroBiogen Co., Ltd ยท Tests: KDS2010, Placebo
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy